Richard Wu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients (NCT05176470) | Richard Wu | 2022-07-01 |
Track Richard Wu automatically
Every clearance here is in the API, with alerts when new ones post.